Misonix, Inc. specializes in the development and commercialization of ultrasonic surgical devices for neurosurgical, spinal, advanced wound care, and general surgery procedures. Its innovative, ultrasonic platforms for surgical applications include aspirators for the removal of both soft and hard tissue, instruments for laparoscopic cutting and coagulation, devices for wound cleansing and debridement, products for precision bone cutting and sculpting, and liposuction instrumentation for improving body aesthetics. The Company's portfolio of products are all based upon the unique properties of ultrasound and its ability to differentiate hard and soft tissue for different clinical requirements. 

TypePublic
HQFarmingdale, US
Founded1959
Size (employees)92 (est)
Websitemisonix.com
Misonix was founded in 1959 and is headquartered in Farmingdale, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Misonix Office Locations

Misonix has an office in Farmingdale
Farmingdale, US (HQ)
1938 New Hwy
Show all (1)
Report incorrect company information

Misonix Financials and Metrics

Misonix Revenue

Misonix's revenue was reported to be $36.68 m in FY, 2018
USD

Revenue (FY, 2018)

36.7 m

Gross profit (FY, 2018)

26.9 m

Gross profit margin (FY, 2018), %

73.3%

Net income (FY, 2018)

(7.6 m)

EBIT (FY, 2018)

(2.9 m)

Market capitalization (18-Sep-2018)

166.7 m

Closing stock price (18-Sep-2018)

17.7

Cash (30-Jun-2018)

11 m
Misonix's current market capitalization is $166.7 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2018

Revenue

17.1 m22.2 m23.1 m36.7 m

Revenue growth, %

30%4%

Cost of goods sold

5.9 m7.3 m9.8 m

Gross profit

11.1 m14.9 m26.9 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q3, 2018

Revenue

3.1 m4.1 m4.3 m4.5 m5.6 m5.3 m5.3 m6 m5.4 m6.2 m6 m7.2 m28 m

Cost of goods sold

1.3 m1.2 m1.4 m1.6 m1.8 m1.7 m1.8 m1.9 m1.9 m

Gross profit

1.7 m2.9 m2.9 m3 m3.8 m3.6 m3.5 m4.1 m3.6 m

Gross profit Margin, %

56%70%67%65%68%69%66%68%66%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2018

Cash

7 m9.6 m9 m11 m

Accounts Receivable

Inventories

367.8 k441.6 k5.8 m5 m

Current Assets

15.4 m21 m19.3 m21.9 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q3, 2018

Cash

4.7 m5 m5.6 m7.6 m8.3 m8.9 m9.7 m9.6 m8.4 m8.6 m12.8 m11.9 m12.3 m

Inventories

4.2 m4 m4.1 m4.5 m4.3 m4.2 m4.8 m5.4 m5.9 m5.2 m5 m4.9 m5.2 m

Current Assets

11.9 m12.1 m13.1 m15.7 m16.3 m17.1 m20.9 m19.4 m19 m18.1 m21.8 m21.8 m22.8 m

PP&E

1.2 m1.3 m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2018

Net Income

1.4 m5.6 m

Depreciation and Amortization

1.4 m

Inventories

(1 m)(1.3 m)(2.8 m)(1.4 m)

Accounts Payable

Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q3, 2018

Net Income

383.2 k901.2 k454.3 k(521.9 k)(614.8 k)(5.8 m)

Inventories

(146.6 k)40.6 k(733.7 k)(517.3 k)(476.1 k)(797 k)(834.6 k)(1.8 m)(2.6 m)164.1 k(116.9 k)(450 k)(1.2 m)

Accounts Payable

64.5 k377.4 k137.9 k

Cash From Operating Activities

5 k10 k14.9 k5 k10 k14.9 k(1.2 m)
USDY, 2018

Revenue/Employee

398.7 k

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information

Misonix News and Updates

Misonix to Present at the 38th Annual Canaccord Genuity Growth Conference on August 8

FARMINGDALE, N.Y., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that it will be participating in the Canaccord Genuity 38th Annual…
Report incorrect company information

Misonix Company Life and Culture

Report incorrect company information